Navigation Links
Covance Reports Fourth Quarter Pro Forma Net Revenue Of $561 Million, Pro Forma EPS Of $0.73 And Adjusted Net Orders Of $769 Million
Date:1/24/2013

compared to 38 days at both September 30, 2012 and December 31, 2011.

The Company's investor conference call will be webcast on January 25 at 9:00 am ET.  Management's commentary and presentation slides will be available through www.covance.com. 

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues of approximately $2.2 billion, global operations in more than 30 countries, and more than 11,750 employees worldwide.  Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at www.covance.com.

Statements contained in this press release, which are not historical facts, such as statements about prospective earnings, savings, revenue, operations, revenue and earnings growth and other financial results are forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  All such forward-looking statements including the statements contained herein regarding anticipated trends in the Company's business are based largely on management's expectations and are subject to and qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements.  These risks and uncertainties include, without limitation, competitive factors, outsourcing trends in the pharmaceutical industry, levels of industry research and development spending, the Company's ability to continue to attract and retain qualified personnel, the fixed price nature of contracts or the loss or delay of large studies, risks associated with acquisitions and investments, the Company's ability to increase order volume, the pace of translation of orders into revenue in late-stage develo
'/>"/>

SOURCE Covance Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Covance To Present At The William Blair 32nd Annual Growth Stock Conference
2. Covance Reports Second Quarter Pro Forma Net Revenue Of $538 Million, Pro Forma EPS Of $0.65 And Adjusted Net Orders Of $701 Million
3. Covance to Present at the Morgan Stanley Global Healthcare Conference
4. Covance Reports Third Quarter Pro Forma Net Revenue Of $542 Million, Pro Forma EPS Of $0.72 And Adjusted Net Orders Of $701 Million
5. Covance To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
6. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
7. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
8. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
9. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
10. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
11. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 22, 2013 /PRNewswire-iReach/ -- MarketReportsOnline.com announces addition of ... Series (4) 2013 Edition Material and Clinical Trial ... Registration: A Guidebook of Registration Application for Imported ... its online database. The traditional medicines ... always regarded by occidental as mysterious medicines. Until ...
(Date:5/22/2013)... May 22, 2013 Rigel Pharmaceuticals, Inc. (Nasdaq: ... of three programs in development. The first program is ... R348, being developed by Rigel as a treatment for ... at oncology targets and are being conducted by corporate ... BerGenBio AS (BerGenBio) and a ligase inhibitor under development ...
(Date:5/22/2013)... NEWARK, Del. , May 22, 2013 /PRNewswire/ ... today announced the production of a vaccine candidate ... an independent third party laboratory using the iBioLaunch™ ... days as measured from initial antigen sequence information ... (Logo: http://photos.prnewswire.com/prnh/20120419/NY91086LOGO ) The ...
Breaking Medicine Technology:China Pharmaceutical Market Guidebook Series (4) 2013 Report 2China Pharmaceutical Market Guidebook Series (4) 2013 Report 3China Pharmaceutical Market Guidebook Series (4) 2013 Report 4China Pharmaceutical Market Guidebook Series (4) 2013 Report 5Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 2Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 3Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 4iBio Technology Produces Vaccine Candidate for Recently Emerged H7N9 Influenza 2
... N.J., Nov. 9 Unwavering from its pursuit of ... climate, Lutronic, Inc., a leading developer of high quality ... fractional CO2 device priced at under $50,000. , ... to Lutronic,s fractional technology including scanning and stamping operation ...
... (NYSE Amex: KAD ), a leading provider of ... brand, has appointed Stephen Goldsmith to its Board of ... his resignation from the Board. , ... is the Daniel Paul Professor of Government and Director ...
Cached Medicine Technology:Lutronic(R) Unleashes the New MOSAIC CO2 2Arcadia Resources Names Stephen Goldsmith to Board of Directors 2Arcadia Resources Names Stephen Goldsmith to Board of Directors 3
(Date:5/21/2013)... on a large scale is the cornerstone of ... better outcomes, better value and better experience of ... patient-centered medical home model offers a viable solution ... of Health and Human Services, Agency for Healthcare ... more about the processes and determinants of successful ...
(Date:5/21/2013)... 2013 Mecklenburg EMS Agency (Medic) ... a free Community Wellness Fair to educate the public on ... be held on Wednesday, May 22, 2013 from 4:00 pm ... (8100 Old Mallard Creek Road, Charlotte, NC 29262). ... and the Mecklenburg County Department of Social Services ...
(Date:5/21/2013)... 21 May 2013, Paris, France: The Orsiro stent, ... from a biodegradable polymer, demonstrated non-inferiority to the ... endpoint of in-stent late lumen loss at nine ... reported at EuroPCR 2013 today. , The BIOFLOW-II ... tomography (OCT) to quantitatively assess neointimal hyperplasia and ...
(Date:5/21/2013)... Boca Raton, Fla. (PRWEB) May 21, 2013 ... TV program distributed on cable networks and cable channels ... of new episodes on its YouTube channel. The producers ... profiles of companies in the shipping industry, the manufacturing ... program highlights pioneering medical facilities and medical practitioners in ...
(Date:5/21/2013)... 2013 MedMar Healing Center announces ... Second Harvest Food Bank. Twenty-eight businesses, including MedMar Healing Center, ... food drive. The goal is to raise food to help ... facing their families in recent years. , “We like ... those in need,” explains Douglas Chloupek of MedMar Healing Center. ...
Breaking Medicine News(10 mins):Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 2Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 3Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 4Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 5Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 6Health News:Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives 2Health News:Biodegradable stent proves non-inferior to drug-eluting stent 2Health News:In View hosted by Larry King Announces New Videos on its YouTube Channel 2Health News:San Jose Cannabis Club Helps Feed Hungry Children with Second Harvest Food Bank 2
... of developing another tumor stays high throughout life, study finds ... cancer as children face a high lifelong risk for developing ... that appears online May 26 in the Journal of ... studies by following people from birth through age 79. The ...
... funded by pharmaceutical company finds benefits in Abraxane, , , ... affirms that the chemotherapy drug Abraxane is more effective, ... of choice for metastatic breast cancer. , When compared ... by almost seven months, effectively doubling survival. Both are ...
... migraine have strong reason for new optimism concerning a ... "The Future of Migraine: Beyond Just Another Pill," in ... are the basis for an ironic premise. , "Migraine ... patients, families, workplaces, and society," according to the editorial ...
... May 26 The Medical Center of ... in half after an improvement project along the entire ... in June 2008. Medical Center leadership initiated the ... Emergency Department became evident. To help create a strategy ...
... how to avoid them , ... (Vocus) May 26, 2009 -- Avoiding ... you can save a great deal of money in medical expenses, says ... Medical Foundation ( www.petsafetyct.org ) and director of the Connecticut State Animal ...
... reduce the spread of HIV and other sexually ... diverse populations continues to be complex and challenging. ... two-year grant to David Prez-Jimnez, Ph.D., at the ... and assessment of an HIV and other sexually ...
Cached Medicine News:Health News:Drug May Extend Life When Breast Cancer Spreads 2Health News:Drug May Extend Life When Breast Cancer Spreads 3Health News:Mayo Clinic Proceedings: The evolution of migraine from episodic headache to chronic disorder 2Health News:Compirion Healthcare Cuts Emergency Department Throughput by 50% at the Medical Center of Central Georgia 2Health News:Compirion Healthcare Cuts Emergency Department Throughput by 50% at the Medical Center of Central Georgia 3Health News:Compirion Healthcare Cuts Emergency Department Throughput by 50% at the Medical Center of Central Georgia 4Health News:Compirion Healthcare Cuts Emergency Department Throughput by 50% at the Medical Center of Central Georgia 5Health News:CVMF Advises on How to Save Money on Veterinary Bills 2Health News:CVMF Advises on How to Save Money on Veterinary Bills 3Health News:CVMF Advises on How to Save Money on Veterinary Bills 4Health News:HIV prevention program gets a boost from NIMH recovery act funds 2
Fine tying forceps, standard with smooth jaws. For 7-0 to 9-0 sutures....
Maumenee tying forceps is straight with concave-convex jaws and has a round handle with guide pin. For 8-0 to 11-0 sutures....
Anis tying forcep is extra delicate with smooth jaws, curved. For 9-0 to 11-0 sutures....
McPherson titanium tying forceps which is 5 mm long, smooth jaws and straight. Used for 8-0 to 11-0 sutures....
Medicine Products: